apolipoprotein B-editing catalytic
Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi ethnic cohort and with immune cell presentation
... Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3B (APOBEC3B) is a member of the APOBEC family of cystidine deaminases whose canonical function is in innate immune defence ...
9
APOBEC3 deletion increases the risk of breast cancer: a meta- analysis
... or apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3) were combined with polymorphism-specific terms (polymorphism or polymorphisms or variation or variations or variant or ...
8
<p>Berzosertib (VE-822) inhibits gastric cancer cell proliferation via base excision repair system</p>
... required class switch recombination and somatic hypermu- tation; during the process, UNG promotes the former one and suppresses the latter one. 11–13 Moreover, there was also a negative correlation between UNG expression ...
15
Unabated Adenovirus Replication following Activation of the cGAS/STING-Dependent Antiviral Response in Human Cells
... a catalytic subunit of an apolipoprotein B (apoB) mRNA editing enzyme ...the editing activity and dimerization potential of three different mouse APOBEC-1 mutants using in vitro edit- ...
6
Molecular control of HIV 1 postintegration latency: implications for the development of new therapeutic strategies
... APOBEC3G: APOlipoprotein BmRNA Editing Catalytic subunit-like protein 3G; ATF-3: Activating Transcription Factor-3; ATP: Adenosine Tri- Phosphate; Bcl-2: B-cell Lymphoma 2; BRG-1: Brahma- ...
29
New concepts in breast cancer genomics and genetics
... APOBEC: Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like; BRCA1: Breast cancer 1, early onset; BRCA2: Breast cancer 2, early onset; CDH1: Cadherin 1, type 1, E-cadherin ...
11
Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers
... A3B: apolipoprotein B mRA-editing enzyme, catalytic polypeptide-like 3B (=APOBEC3B); ACTN4: activator protein-1, alpha-actinin 4; AEG: adenocarci- noma of the esophago-gastral junction; AJCC: ...
16
Müller glia: stem cells for generation and regeneration of retinal neurons in teleost fish
... Apobec2a/2b, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a/2b; ApoE, apolipoprotein E; Atoh7, atonal homolog 7; BLBP, brain lipid binding protein; BMP, bone ...
30
Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine
... APOBEC: Apolipoprotein B mRNA-editing, enzyme-catalytic, polypeptide-like 3G; BAP1: BRCA1 associated protein-1; BRAF: B-Raf proto-oncogene, serine/threo- nine kinase; ccRCC: clear cell ...
10
Original Article Effect of apolipoprotein B mRNA-editing catalytic polypeptide-like protein-3G in cervical cancer
... [11] Yu W, McPherson JR, Stevenson M, van Eijk R, Heng HL, Newey P, Gan A, Ruano D, Huang D, Poon SL, Ong CK, van Wezel T, Cavaco B, Rozen SG, Tan P, Teh BT, Thakker RV, Morreau H. Whole-Exome Sequencing Studies ...
6
Alpha Interferon Potently Enhances the Anti-Human Immunodeficiency Virus Type 1 Activity of APOBEC3G in Resting Primary CD4 T Cells
... of apolipoprotein B mRNA-editing enzyme-catalytic polypep- tide-like 3G (APOBEC3G) in human primary resting but not activated CD4 T cells and the amounts of APOBEC3G associated with a low ...
13
GLI2 promoter hypermethylation in saliva of children with a respiratory allergy
... APOBEC1: Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1; CCR: Chemokine receptors; CD: Cluster of differentiation; DMRs: Differentially methylated gene regions; EFA: European ...
13
Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout
... The apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1, complementation factor (A1CF), protein is known as a complementation factor for the apolipo- protein B mRNA ...
10
Increased BST2 expression during simian immunodeficiency virus infection is not a determinant of disease progression in rhesus monkeys
... APOBEC: apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like; ART: antiretroviral therapy; BST2: bone marrow stromal cell antigen 2; cDNA: complementary deoxyribonucleic acid; Ct: ...
14
Serum apolipoprotein C3 levels are negatively associated with hepatitis B virus DNA in HBeAg-negative chronic hepatitis B patients
... During the process of normal transport, lipids are combined with apolipoprotein (Apo) [6]. ApoA5 and ApoC3 are important members of Apo family. ApoA5 is found to be located in ApoA1/C3/A4 gene cluster on human ...
7
Uracil within DNA: an actor of antiviral immunity
... dividing cells, and barely detectable levels in differenti- ated and non-dividing cells [34]. In contrast to UNG2 that accumulates in replication foci [42,43], SMUG1 is only expressed in nucleoli where it may have a ...
12
HIV-1 in the United Kingdom: population dynamics and genetic evolution
... and B, are so similar that they would be more accurately classified as sub-subtypes of each other; that they are not is due to reasons for wishing to preserve the historical link with previous literature and ...
289
Apolipoprotein B 100 deficiency Intestinal steatosis despite apolipoprotein B 48 synthesis
... electrophoresis, which suggested that this protein was elaborated only with very low density lipoproteins (VLDL). A radioimmunoassay for apo B employing a polyclonal antisera to plasma LDL gave apparent plasma apo ...
11
Characterization of an abnormal species of apolipoprotein B, apolipoprotein B 37, associated with familial hypobetalipoproteinemia
... apo B-37 was found in very low density lipoproteins, along with the normal apo B species, apo B-100 and apo ...apo B-37, but no other apo B ...apo B-37 were identical to those of ...
12
Physiological serum total bilirubin concentrations were inversely associated with diabetic peripheral neuropathy in Chinese patients with type 2 diabetes: a cross-sectional study
... hepatitis B or C, liver cirrhosis, inflamma- tory or autoimmune diseases, acute infectious disease, cancer, alcoholism, acute or chronic blood loss, hemoly- sis, or red blood cell transfusion, pregnancy or ...
11